Christopher Flint OBrien
CIK 1343124 · Former Chief Medical Officer · last filed 2018-02-07
Christopher Flint OBrien is a Former Chief Medical Officer who has filed 56 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing, for NBIX, was dated Feb 7, 2018. Across all open-market trades the lifetime net is −$27.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.0M across reported positions. 58 SEC filings were submitted jointly with NEUROCRINE BIOSCIENCES INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NBIX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Former Chief Medical Officer | 55,946 | $142.44 | $7.97M | -$27.12M | 56 | 2018-02-07 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-07 | NBIX | Mixed | −3,627 | -$301.0K | EDGAR |
| 2018-01-18 | NBIX | Sell (S) | −1,750 | -$138.5K | EDGAR |
| 2017-11-06 | NBIX | Mixed | — | -$3.22M | EDGAR |
| 2017-10-03 | NBIX | Mixed | — | -$362.8K | EDGAR |
| 2017-09-07 | NBIX | Mixed | — | -$2.58M | EDGAR |
| 2017-07-31 | NBIX | Mixed | — | -$361.2K | EDGAR |
| 2017-05-23 | NBIX | Mixed | — | -$4.96M | EDGAR |
| 2017-04-13 | NBIX | Sell (S) | −13,065 | -$658.8K | EDGAR |
| 2017-02-08 | NBIX | Mixed | −1,206 | -$52.1K | EDGAR |
| 2017-02-06 | NBIX | Sell (S) | −1,500 | -$63.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.